BioSpace News Archive

Craig Hospital, a world-renowned rehabilitation hospital for people who have sustained spinal cord and/or brain injuries, announced today that it has appointed Daniel Frank as its new Chief Financial Officer.

Clean Recovery Centers has announced the addition of Rachel Lane, LMHC, MCAP, as a Therapist to their team. Prior to joining the treatment center, she was a Staff Clinician at the University of South Florida and an Addictions Counselor with Tranquil Shores in Madeira Beach.

From February 12th-14th, iNTERFACEWARE®, a leading healthcare integration provider, will be returning as an exhibitor at HIMSS Global Conference & Exhibition in Orlando, Florida.

Watercrest Senior Living Group proudly welcomes Michael Gall as Executive Director of the newly constructed Sage Park Assisted Living and Memory Care in Kissimmee, Fla.

Spring Mountain Capital, LP (“SMC”) is pleased to announce the sale of Activate Healthcare, LLC (“Activate” or the “Company”), a leader in next-generation workplace primary care clinics for employers, to Paladina Health.

Siris Medical, headquartered in Silicon Valley and Boston, today announced the commercial release of PlanMD™ 2.0, an update of the first AI-powered decision support software for radiation oncologists.

The New Jersey Hospital Association, the state’s oldest and largest healthcare trade association, held its annual awards program Friday during NJHA’s 100th Annual Meeting to honor several individuals for their commitment to the state’s healthcare system and the patients and communities they serve.

Endologix Inc.® (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, announced today that the EC Certificate of Conformity (CE Mark) for the Nellix EndoVascular Aneurysm Sealing System (Nellix System) has been suspended by its Notified Body, GMED, following a voluntary recall and Field Safety Notification (FSN) issued by Endologix on January 4, 2019.

Accuray Inc. (NASDAQ: ARAY) today reported its financial results for the second quarter of fiscal 2019 ended December 31, 2018.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its full year and fourth quarter 2018 financial results on Tuesday, February 5, 2019 after the financial markets close.